Related Experiment Video
Updated: May 7, 2026
Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
Published on: October 25, 2024
Automatic extraction of PET RANO criteria with an externally validated deep learning model: Application to [18F]FDOPA
Timothée Zaragori1,2, Laura Rozenblum3,4, Guido Rovera5
1CHRU-Nancy, Inserm, Université de Lorraine, CIC 1433, Innovation Technologique, Nancy, France.
Background:
Automatic segmentation of gliomas on amino acid PET is essential for quantitative tumor assessment, a pillar in monitoring gliomas under treatment. This study aimed to develop a deep learning model for the automated extraction of PET RANO criteria from [18F]FDOPA PET, with external validation.
Methods:
A total of 635 static [18F]FDOPA PET scans from 3 European centers were retrospectively included for glioma diagnosis, recurrence assessment, or treatment monitoring. The training cohort comprised 530 scans from Nancy Hospital, with external validation and test sets from Pitié-Salpêtrière Hospital (n = 66) and Turin Hospital (n = 39). Ground-truth segmentations followed international guidelines. A 3D U-Net was trained to segment tumor and healthy brain volumes. Performance was evaluated using the Dice coefficient using the whole tumor volume. Quantitative agreement for PET RANO criteria 1.0 parameters, tumor-to-background ratios (TBRmean, TBRmax) and metabolic tumor volume (MTV), was assessed at the lesion level.
Results:
Tumor segmentation achieved Dice of 0.925 (0.841; 0.970) in training, 0.885 (0.829; 0.925) in validation, and 0.851 (0.733; 0.911) in the test set. At lesion level, agreement with expert quantification was high, with low bias and strong reliability for MTV (2.293 [-4.734; 9.321] mL), TBRmax (0.056 [-0.189; 0.301]), and TBRmean (-0.139 [-0.424; 0.146]) and intraclass correlation coefficients superior to 0.93. Measurable lesions were correctly identified in more than 97% of cases.
Conclusion:
Our [18F]FDOPA PET deep learning model (available at https://github.com/IADI-Nancy/FDOPA-PET-GliomaSeg) demonstrates robust multicenter performance and enables fully automated, reproducible quantification, supporting broader clinical adoption of amino acid PET in neuro-oncology.
